Trial Profile
A retrospcetive observational study investigating efficacy and safety and patients' perception about difficulty of dosage regimen with trifluridine/tipiracil in cancer patients in Spain
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jun 2017
Price :
$35
*
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer; Gastric cancer; Gastrointestinal cancer; Oesophageal cancer; Small cell lung cancer; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2017 New trial record
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology